0001836891-21-000002.txt : 20210622
0001836891-21-000002.hdr.sgml : 20210622
20210622152427
ACCESSION NUMBER: 0001836891-21-000002
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210622
DATE AS OF CHANGE: 20210622
EFFECTIVENESS DATE: 20210622
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Angarus Therapeutics, Inc.
CENTRAL INDEX KEY: 0001836891
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-384604
FILM NUMBER: 211034669
BUSINESS ADDRESS:
STREET 1: 321 DEDALERA DR.
CITY: PORTOLA VALLEY
STATE: CA
ZIP: 94028
BUSINESS PHONE: 650-575-1702
MAIL ADDRESS:
STREET 1: 321 DEDALERA DR.
CITY: PORTOLA VALLEY
STATE: CA
ZIP: 94028
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001836891
Angarus Therapeutics, Inc.
321 DEDALERA DR.
PORTOLA VALLEY
CA
CALIFORNIA
94028
650-575-1702
DELAWARE
None
None
Corporation
true
2018
Nigel
Ray
c/o Angarus Therapeutics, Inc.
321 Dedalera Dr.
Portola Valley
CA
CALIFORNIA
94028
Executive Officer
Director
Chih-Ping
Liu
c/o Angarus Therapeutics, Inc.
321 Dedalera Dr.
Portola Valley
CA
CALIFORNIA
94028
Director
Peter
Langecker
c/o Angarus Therapeutics, Inc.
321 Dedalera Dr.
Portola Valley
CA
CALIFORNIA
94028
Director
Jean
Liu
c/o Angarus Therapeutics, Inc.
321 Dedalera Dr.
Portola Valley
CA
CALIFORNIA
94028
Director
Biotechnology
Decline to Disclose
- 06b
true
0001836891-21-000001
2020-12-14
false
true
false
0
CIM SECURITIES, LLC
120852
None
None
6898 S. UNIVERSITY BLVD
SUITE 270
CENTENNIAL
CO
COLORADO
80122
AK
ALASKA
CA
CALIFORNIA
CO
COLORADO
CT
CONNECTICUT
FL
FLORIDA
GA
GEORGIA
IL
ILLINOIS
IN
INDIANA
KS
KANSAS
ME
MAINE
MI
MICHIGAN
NJ
NEW JERSEY
NY
NEW YORK
ND
NORTH DAKOTA
PA
PENNSYLVANIA
SC
SOUTH CAROLINA
TN
TENNESSEE
TX
TEXAS
UT
UTAH
VA
VIRGINIA
WA
WASHINGTON
WI
WISCONSIN
false
9745976
9745976
0
false
77
456106
true
0
0
false
Angarus Therapeutics, Inc.
/s/ Nigel Ray
Nigel Ray
Chief Executive Officer
2021-06-22